Detalhe da pesquisa
1.
Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells.
BJU Int
; 125(1): 89-102, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31392791
2.
Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2.
Br J Cancer
; 114(11): 1235-42, 2016 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-27115470
3.
Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.
Immunology
; 139(3): 377-85, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23374145
4.
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models.
Front Immunol
; 14: 1196829, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37465665
5.
The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
Apoptosis
; 17(2): 164-73, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22109882
6.
Immunotherapy of prostate cancer: identification of new treatments and targets for therapy, and role of WAP domain-containing proteins.
Biochem Soc Trans
; 39(5): 1433-6, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21936828
7.
Immune checkpoint blockade - a treatment for urological cancers?
BJU Int
; 118(4): 498-500, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27367558
8.
Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in Escherichia coli and Purification.
Front Mol Biosci
; 8: 755764, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34778376
9.
Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer.
Front Oncol
; 11: 621550, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33777767
10.
A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro.
Mol Biol Rep
; 37(4): 1801-14, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19597962
11.
The potential of immunomodulatory drugs in the treatment of solid tumors.
Future Oncol
; 6(9): 1479-84, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20919830
12.
Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model.
Immunotargets Ther
; 9: 115-130, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32802803
13.
IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.
Front Immunol
; 11: 594620, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33537030
14.
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
Cancer Immunol Immunother
; 58(7): 1033-45, 2009 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19009291
15.
Tools to investigate biomarker expression in bladder cancer progression.
BJU Int
; 112(3): 404-6, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23826845
16.
Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions.
Nat Biotechnol
; 20(10): 1011-7, 2002 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-12219077
17.
Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope.
Front Oncol
; 12: 1021870, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36158670
18.
HES1 in immunity and cancer.
Cytokine Growth Factor Rev
; 30: 113-7, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27066918
19.
Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking.
Biochem Biophys Rep
; 7: 328-337, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28955923
20.
Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.
Oncoimmunology
; 4(4): e1002720, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26155387